Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare coverage process

This article was originally published in The Gray Sheet

Executive Summary

Recently released Health Care Financing Administration notice describing procedures and timeframes for obtaining coverage decisions ("The Gray Sheet" April 26, p. 3) fails to provide an "opportunity for stakeholders to have an early, collaborative meeting with" HCFA staff "so that a written, mutual agreement may be reached on what specific information" is needed to make a coverage determination, Medical Alley says in an April 28 letter to Jeffrey Kang, director of HCFA's Office of Clinical Standards and Quality. The lack of such an agreement "creates a tenuous foundation for the entire coverage decision-making process," according to the group, which plans to discuss the matter further with Kang during a May 12 conference call

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011706

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel